Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Here’s what to know about Tori Spelling’s weight loss journey in her own words. Spelling revealed in April on her podcast ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...